144 related articles for article (PubMed ID: 9117184)
1. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
Ronday HK; Smits HH; Quax PH; van der Pluijm G; Löwik CW; Breedveld FC; Verheijen JH
Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
[TBL] [Abstract][Full Text] [Related]
2. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
[TBL] [Abstract][Full Text] [Related]
3. Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.
Quax PH; Pedersen N; Masucci MT; Weening-Verhoeff EJ; Danø K; Verheijen JH; Blasi F
Cell Regul; 1991 Oct; 2(10):793-803. PubMed ID: 1666303
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
5. Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface.
Cerinic MM; Generini S; Partsch G; Pignone A; Dini G; Konttinen YT; Del Rosso M
Life Sci; 1998; 63(6):441-53. PubMed ID: 9718068
[TBL] [Abstract][Full Text] [Related]
6. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
[TBL] [Abstract][Full Text] [Related]
8. The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells.
Reiter LS; Kruithof EK; Cajot JF; Sordat B
Int J Cancer; 1993 Feb; 53(3):444-50. PubMed ID: 8381394
[TBL] [Abstract][Full Text] [Related]
9. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression.
Lansink M; Koolwijk P; van Hinsbergh V; Kooistra T
Blood; 1998 Aug; 92(3):927-38. PubMed ID: 9680361
[TBL] [Abstract][Full Text] [Related]
10. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
Kroon ME; Koolwijk P; van Goor H; Weidle UH; Collen A; van der Pluijm G; van Hinsbergh VW
Am J Pathol; 1999 Jun; 154(6):1731-42. PubMed ID: 10362798
[TBL] [Abstract][Full Text] [Related]
11. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
12. Urokinase synthesis and binding by glomerular epithelial cells in culture.
Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
[TBL] [Abstract][Full Text] [Related]
13. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
[TBL] [Abstract][Full Text] [Related]
15. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson CL; Pijuan-Thompson V; Olman MA; Gillespie GY; Yacoub IZ
Am J Pathol; 1995 May; 146(5):1150-60. PubMed ID: 7747809
[TBL] [Abstract][Full Text] [Related]
18. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]